Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinoma

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2021 · 112.5K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn, Shukui Qin, Masafumi Ikeda et al. · New England Journal of Medicine · 2020 · 7.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Management of Hepatocellular Carcinoma *

Jordi Bruix, Morris Sherman · Hepatology · 2005 · 5.9K citations · Full text

Medicine, Oncology, Surgery +17

AASLD guidelines for the treatment of hepatocellular carcinoma

Julie K. Heimbach, Laura Kulik, Richard S. Finn et al. · Hepatology · 2017 · 4.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +12

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

Paolo Angeli, Mauro Bernardi, Càndid Villanueva et al. · Journal of Hepatology · 2018 · 2.8K citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14